US 6,475,804 B1Granted

Composition and method for diagnosing auto-immune hepatitis

OwnerAnsgar W. Lohseinventor

Life of this patent

Estimating the term…

Abstract

A composition and method for the diagnosis of autoimmune hepatitis. The composition, which contains SLA antigens detects soluble liver antigen (SLA) auto-antibodies, which occur in sera of patients suffering from chronic hepatitis.

Claims6

Dependent claims

A composition for detecting the presence of soluble liver antigen auto-antibodies in a patient's blood serum, comprising an antigen that is recognized by soluble liver antigen auto-antibodies, wherein said antigen is selected from the group consisting of antigens having amino acid sequence SEQ ID NO:1, and SEQ ID NO:2.

Dependencies are inferred from the claim text.

Facts

Application: 09/249,020Filed 12 Feb 1999
Priority: DE 198 05 81513 Feb 1998
Granted: 5 Nov 2002
Term ends: Not estimatedThe source records don’t support an estimate.

Classification11 codes

G01N 33/564
Immunoassay; Biospecific binding assay; Materials therefor: for pre-existing immune complex or autoimmune disease , i.e. systemic lupus…
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
C07K 14/4713
Not used: autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus;…

Family

No related US applications are recorded in the indexed filing history.

Timeline

Citations

Open elsewhere

patentgrep

Loading patent…

Abstract

Facts

Application

09/249,020Filed 12 Feb 1999

Priority

DE 198 05 81513 Feb 1998

Granted

5 Nov 2002

Term ends

Not estimatedThe source records don’t support an estimate.

Classification11 codes

G01N 33/564
Immunoassay; Biospecific binding assay; Materials therefor: for pre-existing immune complex or autoimmune disease , i.e. systemic lupus…
A61P 1/00
Drugs for disorders of the alimentary tract or the digestive system
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
C07K 14/4713
Not used: autoimmune diseases, e.g. Insulin-dependent diabetes mellitus, multiple sclerosis, rheumathoid arthritis, systemic lupus erythematosus;…